FF EAI Robotics Ecosystem, Inc. (FFR)
1.50
-0.30
(-16.67%)
USD |
NASDAQ |
Oct 12, 16:00
1.48
-0.02
(-1.33%)
After-Hours: 05:40
FF EAI Robotics Ecosystem Enterprise Value : 35.22M for Oct. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 35.22M |
| October 09, 2026 | 41.29M |
| October 08, 2026 | 40.69M |
| October 07, 2026 | 41.09M |
| October 06, 2026 | 32.80M |
| October 05, 2026 | 27.74M |
| October 02, 2026 | 29.76M |
| October 01, 2026 | 29.56M |
| September 30, 2026 | 31.38M |
| September 29, 2026 | 25.31M |
| September 28, 2026 | 38.46M |
| September 25, 2026 | 39.88M |
| September 24, 2026 | 33.61M |
| September 23, 2026 | 38.46M |
| September 22, 2026 | 33.40M |
| September 21, 2026 | 27.33M |
| September 18, 2026 | 26.93M |
| September 17, 2026 | 25.92M |
| September 16, 2026 | 24.30M |
| September 15, 2026 | 25.61M |
| September 14, 2026 | 28.95M |
| September 11, 2026 | 23.01M |
| September 10, 2026 | 19.85M |
| September 09, 2026 | 19.15M |
| September 08, 2026 | 18.84M |
| Date | Value |
|---|---|
| September 04, 2026 | 19.23M |
| September 03, 2026 | 18.96M |
| September 02, 2026 | 20.47M |
| September 01, 2026 | 20.66M |
| August 31, 2026 | 21.33M |
| August 28, 2026 | 20.71M |
| August 27, 2026 | 21.93M |
| August 26, 2026 | 23.49M |
| August 25, 2026 | 23.72M |
| August 24, 2026 | 23.82M |
| August 21, 2026 | 27.54M |
| August 20, 2026 | 28.65M |
| August 19, 2026 | 36.24M |
| August 18, 2026 | 31.58M |
| August 17, 2026 | 19.24M |
| August 14, 2026 | 18.57M |
| August 13, 2026 | 18.85M |
| August 12, 2026 | 19.89M |
| August 11, 2026 | 21.01M |
| August 10, 2026 | 20.84M |
| August 07, 2026 | 21.51M |
| August 06, 2026 | 21.58M |
| August 05, 2026 | 20.48M |
| August 04, 2026 | 21.02M |
| August 03, 2026 | 20.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cibus, Inc. | 378.94M |
| Arrowhead Pharmaceuticals, Inc. | 8.346B |
| NovelStem International Corp. | 2.190M |
| Oncolytics Biotech, Inc. | 55.32M |
| Sangamo Therapeutics, Inc. | 53.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.188M |
| Total Expenses (Quarterly) | 4.188M |
| EPS Diluted (Quarterly) | -0.2064 |
| Earnings Yield | -628.8% |
| Normalized Earnings Yield | -608.16 |